Clinical predictors of shunt response in the diagnosis and treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis - Scorecard - MDSpire

Clinical predictors of shunt response in the diagnosis and treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis

  • By

  • Santhosh G. Thavarajasingam

  • Mahmoud El-Khatib

  • Mark Rea

  • Salvatore Russo

  • Johannes Lemcke

  • Lana Al-Nusair

  • Peter Vajkoczy

  • July 8, 2021

  • 0 min

Share

Clinical Scorecard: Identifying Clinical Factors Associated with Shunt Response in Idiopathic Normal Pressure Hydrocephalus: A Systematic Review and Meta-Analysis

At a Glance

CategoryDetail
ConditionIdiopathic Normal Pressure Hydrocephalus (iNPH)
Key MechanismsCSF shunting to improve symptoms associated with hydrocephalus including dementia, gait disturbance, and urinary incontinence
Target PopulationAdult patients diagnosed with idiopathic normal pressure hydrocephalus
Care SettingNeurosurgical and neurological clinical settings involving diagnosis and management of iNPH

Key Highlights

  • Shunt response (SR) is the gold standard for diagnosing and treating iNPH, with reported improvement rates varying from 46.7% to 90%.
  • Diagnostic tests include clinical features, tap test (TT), infusion test (IT), extended lumbar drainage (ELD), and intracranial pressure monitoring (ICPM), but guidelines lack explicit cut-off values.
  • This systematic review and meta-analysis included 35 studies from 2003 to 2020, assessing diagnostic effectiveness and predictors of shunt response with low to moderate risk of bias.

Guideline-Based Recommendations

Diagnosis

  • Use a combination of clinical features (Hakim’s triad), radiological confirmation, and diagnostic tests such as TT, IT, ELD, and ICPM to aid diagnosis of iNPH.
  • Radiological and biochemical markers should be considered but require separate analysis beyond this review.
  • Objective functional grading pre- and post-shunting (minimum 3 months) is recommended to assess shunt response.

Management

  • CSF shunt surgery remains the primary treatment for iNPH patients who demonstrate potential for shunt responsiveness.
  • Patient selection for shunting should consider presenting symptoms, with gait disturbance as a primary symptom associated with higher likelihood of response.

Monitoring & Follow-up

  • Postoperative functional grading and clinical follow-up at least 3 months after shunting to evaluate treatment effectiveness.
  • Use of standardized diagnostic accuracy tools and consistent evaluation methods to monitor patient outcomes.

Risks

  • Potential misdiagnosis due to symptom overlap with other pathologies mimicking iNPH.
  • Variability in shunt response rates highlights the importance of careful patient selection and diagnostic evaluation.

Patient & Prescribing Data

Adults diagnosed with idiopathic normal pressure hydrocephalus undergoing CSF shunt surgery

Shunt surgery improves symptoms in a variable proportion of patients; gait disturbance as a presenting symptom may predict better shunt responsiveness.

Clinical Best Practices

  • Employ comprehensive diagnostic evaluation including clinical, radiological, and CSF dynamic tests to improve patient selection for shunting.
  • Use validated functional grading systems pre- and post-shunting to objectively assess patient improvement.
  • Recognize the limitations and heterogeneity in diagnostic test performance and interpret results within clinical context.
  • Maintain awareness of the lack of explicit cut-off values in current guidelines and apply clinical judgment accordingly.

References

Original Source(s)

Related Content